CASP3 and cancer: One of the standout features of napabucasin is its ability to induce apoptosis through the activation of both intrinsic and extrinsic pathways, significantly elevating the expression of cleaved caspase-3 and PARP in various cancer cell lines and showing promise as a treatment for drug-resistant cancers.